Sutro Biopharma Inc. (NASDAQ:STRO)
Old Forum Content for STRO
Make a Forum Post Become a member to view recent forum posts. Already a member? Sign in here.- cdmdave: $STRO - My friend works for a relocation company that's been moving people to San Fran to work for Sutro. Chart looks good to me for a reversal. Anyone else? Sutro Biopharma, Inc. (NASDAQ: STRO), a clinical-stage drug discovery, development and manufacturing company focused on the application of precise protein engineering and rational design to create next-generation cancer and autoimmune therapeutics.
- geotheo: #IPOs- IPOs expected to price: Vioma Technology ($VIOT) on September 24; Capital Bancorp ($CBNK), Entasis Therapeutics ($ETTX), SVMK ($SVMK), Arco Platform ($ARCE) and CooTek Cayman ($CTK) on September 25; Sutro Biopharma ($STRO), RA Medical Systems ($RMED), LAIX ($LAIX), Urovant Sciences ($UROV) and Arvinas ($ARVN) on September 26; Gristone Oncology ($GRTS) on September 27 IPO lockup expirations: GreenTree Hospitality (NYSE:$GHG), OP Bancorp (NASDAQ:$OPBK), Homology Medicines (NASDAQ:$FIXX), Bilibili (NASDAQ:$BILI) and OneSmart Internet Education (NYSE:$ONE) on September 24; Iqiyi (NASDAQ:$IQ) Unum Therapeutics (NASDAQ:$UMRX) and Genprex (NASDAQ:$GNPX) on September 25.
Stock Price | $3.42 |
Change | 0.00% |
Volume | 473,920 |
Sutro Biopharma Inc is a clinical stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers.
Request Video of STROAlready a member? Sign in here.
Past Month
Leading Peers
-
$11.69 300.35%
-
$12.63 261.95%
-
$6.39 139.73%
Past Month
Lagging Peers
-
$27.55 -81.53%
-
$6.16 -76.82%
-
$13.73 -58.64%
Dan Fitzpatrick
Stock Market Mentor gives you EVERYTHING you need to succeed in the market; all in one place. How easy is that? Dan Fitzpatrick and his elite community of traders share trading ideas, strategies and much more. Dan Fitzpatrick--a world class Technical Analyst, trading coach and regular CNBC contributor--gives you access to all of this with a 30 day trial membership for just $7.77. Get started TODAY and start trading better TOMORROW with the following premium content:
- Nightly video Strategy Sessions with a game plan for tomorrow
- Got a stock you want Dan to look at? Just ask.
- Patent pending video alerts instantly delivered to you when one of Dan’s trading signals is triggered. This is not your typical price alert. This is a short video explaining the action you need to take to make money. No more “Woulda, coulda, shoulda”
- Access to over 90,400 stock analysis videos
- Access an ever expanding library (90,400) of educational videos that will save you time and make you money
Join a team of friends and traders that have one thing in common; a burning desire to succeed.
Become a Member Today!
Gain immediate access to all our exclusive articles, features, how-to's, discussion group and much more...
Satisfaction Guaranteed!
Your Stock Market Mentor membership comes with a 30 day, no questions asked, 100% money back guarantee!